Adulterated sexual enhancement supplements: More Than Mojo

JAMA Internal Medicine

Volumn 173, Issue 13, 2013, Pages 1169-1170

  Cohen, Pieter A ^a   Venhuis, Bastiaan J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; GLIBENCLAMIDE; LIDOCAINE; NAPROXEN; NICOTINIC ACID; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; SULFONYLUREA; TADALAFIL; YOHIMBINE;

BLOOD PRESSURE; CORPUS CAVERNOSUM; DIET SUPPLEMENTATION; DIZZINESS; DRUG CONTRAINDICATION; DYSPEPSIA; FLUSHING; FOOD AND DRUG ADMINISTRATION; HEALTH HAZARD; HUMAN; LONG TERM EXPOSURE; MASS SPECTROMETRY; PRESCRIPTION; PRIORITY JOURNAL; SEXUALITY; SHORT SURVEY; SIDE EFFECT; UNITED STATES;

DIETARY SUPPLEMENTS; DRUG CONTAMINATION; ERECTILE DYSFUNCTION; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; SEXUAL BEHAVIOR; SULFONES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84879998716     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.854     Document Type: Short Survey

References (10)

1. US Food and Drug Administration. Tainted supplements CDER. http://www.accessdata.fda.gov/scripts/sda/sdNavigation.cfm?filter= &sortColumn=1d&sd=tainted-supplements-cder&page=1. Accessed December 6, 2012.
2. Cohen PA, Benner C, McCormick D. Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States. J Gen Intern Med. 2012;27(1):51-56.
3. Australian Government, Therapeutic Goods Administration. Safety advisory: Rock Hard for Men tablets. August 29, 2012. http://www.tga.gov.au/safety/ alerts-medicine-rock-hard-120829.htm. Accessed December 6, 2012.
4. Poon WT, Lam YH, Lee HH, et al. Outbreak of hypoglycaemia: sexual enhancement products containing oral hypoglycaemic agent. Hong Kong Med J. 2009;15(3):196-200.
5. Canham M. Feds plow new ground in spiked supplement case. Salt Lake City Tribune. October 1, 2011. http://www.sltrib.com/sltrib/news/52657684-78/harvey- company-products-case.html.csp. Accessed April 3, 2013.
6. Cohen PA. Assessing supplement safety - the FDA's controversial proposal. N Engl J Med. 2012;366(5):389-391.
7. Low MY, Zeng Y, Li L, et al. Safety and quality assessment of 175 illegal sexual enhancement products seized in red-light districts in Singapore. Drug Saf. 2009;32(12):1141-1146.
8. Venhuis BJ, de Kaste D. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks. J Pharm Biomed Anal. 2012;69:196-208.
9. Food and Drug Administration. Public notification: "Mojo Nights" contains hidden drug ingredients. May 25, 2012. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/ MedicationHealthFraud/ucm305594.htm Accessed December 6, 2012.
10. Balayssac S, Gilard V, Zedde C, Martino R, Malet-Martino M. Analysis of herbal dietary supplements for sexual performance enhancement: first characterization of propoxyphenylthiohydroxyhomosildenafil and identification of sildenafil, thiosildenafil, phentolamine and tetrahydropalmatine as adulterants. J Pharm Biomed Anal. 2012;63:135-150.